<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/on-the-potential-role-of-mri-biomarkers-of-copd-to-guide-bronchoscopic-lung-volume-reduction/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/on-the-potential-role-of-mri-biomarkers-of-copd-to-guide-bronchoscopic-lung-volume-reduction/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2018-01-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2018-01-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/on-the-potential-role-of-mri-biomarkers-of-copd-to-guide-bronchoscopic-lung-volume-reduction/"},"url":"https://clinicaltree.github.io/posts/on-the-potential-role-of-mri-biomarkers-of-copd-to-guide-bronchoscopic-lung-volume-reduction/"}</script><title>On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1517418000" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jan 31, 2018 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Colin J. Adams MD</a> </em>, <em> <a href="">Dante P.I. Capaldi BSc</a> </em>, <em> <a href="">Robert Di Cesare</a> </em>, <em> <a href="">David G. McCormack MD FRCPC</a> </em>, <em> <a href="">Grace Parraga PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="3226 words"> <em>17 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In patients with severe emphysema and poor quality of life, bronchoscopic lung volume reduction (BLVR) may be considered and guided based on lobar emphysema severity. In particular, x-ray computed tomography (CT) emphysema measurements are used to identify the most diseased and the second–most diseased lobes as BLVR targets. Inhaled gas magnetic resonance imaging (MRI) also provides chronic obstructive pulmonary disease (COPD) biomarkers of lobar emphysema and ventilation abnormalities. Our objective was to retrospectively evaluate CT and MRI biomarkers of lobar emphysema and ventilation in patients with COPD eligible for BLVR. We hypothesized that MRI would provide complementary biomarkers of emphysema and ventilation that help determine the most appropriate lung lobar targets for BLVR in patients with COPD.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>We retrospectively evaluated 22 BLVR-eligible patients from the Thoracic Imaging Network of Canada cohort (diffusing capacity of the lung for carbon monoxide = 37 ± 12% predicted , forced expiratory volume in 1 second = 34 ± 7% predicted , total lung capacity = 131 ± 17% predicted , and residual volume = 216 ± 36% predicted ). Lobar CT emphysema, measured using a relative area of &lt;−950 Hounsfield units (RA 950 ) and MRI ventilation defect percent, was independently used to rank lung lobe disease severity.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In 7 of 22 patients, there were different CT and MRI predictions of the most diseased lobe. In some patients, there were large ventilation defects in lobes not targeted by CT, indicative of a poorly ventilated lung. CT and MRI classification of the most diseased and the second–most diseased lobes showed a fair-to-moderate intermethod reliability (Cohen κ = 0.40–0.59).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>In this proof-of-concept retrospective analysis, quantitative MRI ventilation and CT emphysema measurements provided different BLVR targets in over 30% of the patients. The presence of large MRI ventilation defects in lobes next to CT-targeted lobes might also change the decision to proceed or to guide BLVR to a different lobar target.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Chronic obstructive pulmonary disease (COPD) is characterized by a chronic airflow limitation associated with airway inflammation due to long-term exposure to inhaled toxins and particles . In patients with COPD, emphysematous tissue destruction and narrowing of the small airways contribute to airflow limitation , lung hyperinflation, dyspnea, and worsening quality of life . Emphysema is inexorably progressive and irreversible, whereas lung hyperinflation also worsens over time and leads to worsening lung compliance, loss of exercise capacity, increased frequency of exacerbations, and a significant decline in quality of life . To improve symptoms and quality of life in patients with very severe COPD and extensive emphysema, lung volume reduction techniques were developed to selectively reduce or remove emphysematous tissue .</p><p>The overarching goal of lung volume reduction methods is to improve lung function and to decrease hyperinflation, which together result in improved patient quality of life and functional status . Such surgical approaches, however, are associated with significant morbidity and mortality . However, in a specific subgroup of patients with heterogeneous upper lobe predominant emphysema and poor functional status, there were significant benefits , including modest improvements in quality of life . Since then, a number of minimally invasive bronchoscopic lung volume reduction (BLVR) approaches have been developed with the goal of improving outcomes and diminished morbidity and mortality associated with the procedure. Several methods have been pioneered, including coils to collapse large airways , one-way endobronchial valves to promote passive collapse and deflation over time , and thermal vapor ablation to create an inflammatory response with subsequent scarring and loss of volume . Collateral ventilation is an important determinant of optimal BLVR outcomes , although recent studies showed that BLVR using vapor ablation may be successful regardless of interlobar or intralobar collateral ventilation . For all of these approaches, typically one or two severely diseased lobes are targeted with the aim of diverting blood flow and ventilation to remaining areas of healthier lung parenchymas .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-subjects"><span class="mr-2">Study Subjects</span><a href="#study-subjects" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="pulmonary-function-tests"><span class="mr-2">Pulmonary Function Tests</span><a href="#pulmonary-function-tests" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-acquisition"><span class="mr-2">Image Acquisition</span><a href="#image-acquisition" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-analysis"><span class="mr-2">Image Analysis</span><a href="#image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>DSC=2|VDP∩RA950||VDP|+|RA950| D</p><p>S</p><p>C</p><p>=</p><p>2</p><p>|</p><p>V</p><p>D</p><p>P</p><p>∩</p><p>R</p><p>A</p><p>950</p><p>|</p><p>|</p><p>V</p><p>D</p><p>P</p><p>|</p><p>+</p><p>|</p><p>R</p><p>A</p><p>950</p><p>|</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistics"><span class="mr-2">Statistics</span><a href="#statistics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Subject Demographic and Pulmonary Function Measurements</p><p>Mean (±SD) All ( <em>n</em> = 22) Age (y) 69 (9) Male, <em>n</em> 14 BMI (kg/m 2 ) 25 (4) Pack-year history (y) 60 (35) FEV 1 , % pred 34 (7) FVC, % pred 74 (17) FEV 1 /FVC (%) 46 (9) TLC, % pred 131 (17) RV, % pred 216 (36) RV/TLC (%) 164 (18) R AW , % pred 304 (126) DL CO , % pred 37 (12) 6MWD (min) 325 (73) RA 950 (%) 20 (10) VDP (%) 33 (9) DSC (%) 29 (12) SOC RA950 (%) 40 (14)</p><p>% pred , percent of predicted value; 6MWD, 6-minute walk test distance; BMI, body mass index; DL CO , diffusing capacity for carbon monoxide; DSC, dice similarity coefficient; FEV 1 , forced expiratory volume in 1 second; FVC, forced vital capacity; RA 950 , relative area of computed tomography density histogram with attenuation values of &lt;−950 HU; R AW , airways resistance; RV, residual volume; SD, standard deviation; SOC, spatial overlap coefficient normalized by RA 950 ; TLC, total lung capacity; VDP, ventilation defect percent.</p><p>Table 2</p><p>Participant Listing of Demographic and Other Measurements</p><p>Subject Age (y) FEV 1 , % pred TLC, % pred RV, % pred RV/TLC (%) DL CO , % pred RA 950 (%) VDP (%) DSC (%) SOC RA950 (%) 1 71 45 127 186 63 31 21 31 38 47 2 48 43 148 189 36 41 20 22 21 23 3 78 38 123 186 58 29 23 32 29 35 4 72 40 135 210 67 54 7 21 14 28 5 51 40 114 208 54 46 12 42 28 64 6 74 30 135 236 66 39 22 37 38 52 7 60 21 102 205 65 45 9 30 16 34 8 68 23 124 214 76 — 27 29 31 33 9 76 32 125 220 64 40 16 36 27 45 10 65 39 120 156 54 63 8 26 18 36 11 78 42 161 221 67 27 19 32 28 37 12 73 34 165 289 64 37 17 40 32 53 13 75 28 141 267 71 17 29 33 38 40 14 67 37 154 265 72 21 32 41 46 53 15 61 30 128 222 71 30 24 42 40 54 16 74 34 141 225 59 24 33 57 51 69 17 63 22 116 180 64 41 23 32 29 34 18 63 38 111 183 55 40 8 26 15 31 19 85 38 124 194 63 36 18 30 24 32 20 73 32 133 230 65 35 15 14 15 14 21 72 26 155 291 68 21 52 44 55 51 22 73 41 107 172 58 54 8 23 13 24 Mean (±SD) 69 (9) 34 (7) 131 (17) 216 (36) 63 (8) 37 (12) 20 (10) 33 (9) 29 (12) 40 (14)</p><p>% pred , percent of predicted value; DL CO , diffusing capacity for carbon monoxide; DSC, dice similarity coefficient; FEV 1 , forced expiratory volume in 1 second; RA 950 , relative area of computed tomography density histogram with attenuation values of &lt;−950 HU; RV, residual volume; SD, standard deviation; SOC, spatial overlap coefficient normalized by RA 950 ; TLC, total lung capacity; VDP, ventilation defect percent.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OnthePotentialRoleofMRIBiomarkersofCOPDtoGuideBronchoscopicLungVolumeReduction/0_1s20S1076633217303689.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OnthePotentialRoleofMRIBiomarkersofCOPDtoGuideBronchoscopicLungVolumeReduction/0_1s20S1076633217303689.jpg" alt="Figure 1, Magnetic resonance and CT images in representative patients with severe chronic obstructive pulmonary disease that meet the inclusion criteria for bronchoscopic lung volume reduction. Top to bottom : CT images ( gray scale ) showing low-attenuating regions below −950 HU (RA 950 ) in yellow, CT images showing low-attenuation clusters and CT airway tree, and hyperpolarized MRI ventilation images ( blue ) coregistered with anatomic proton pulmonary MRI ( grayscale ) for S1 (female, age = 71 years, FEV 1 = 45% pred , FEV 1FVC = 41%), S10 (female, age = 65 years, FEV 1 = 39% pred , FEV 1FVC = 34%), S8 (female, age = 68 years, FEV 1 = 23% pred , FEV 1FVC = 38%), and S21 (male, age = 72 years, FEV 1 = 26% pred , FEV 1FVC = 28%). Color outlines indicate the segmented lobe delineations ( red = right upper lobe, purple = right middle lobe, gold = right lower lobe, green = left upper lobe, and blue = left lower lobe). CT, computed tomography; FEV 1 , forced expiratory volume in 1 second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; LAC, low-attenuating cluster; MRI, magnetic resonance imaging." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>VDP and RA 950 Classification of Most Diseased Lobes by Participant</p><p><a href="APKAICLNFGBCWWYGVIZQ" class="popup img-link "><img data-src="https://d1niluoi1dd30v.cloudfront.net/10766332/S1076633217X00135/S1076633217303689/xacra4085-fig-5001.jpg?Signature=EOHWUn%7EI-Yy-0c6SezoWI0lF8iIvfO5dhrdyxtcZuMzupCBytc908ISlRzCvsjBxrmI0lmmZrBMZSQtA03Rxeq8Yz92PmdZ3JE-Vv2tMpLQSTe3TSAOJsNK8NE7rap9lyyl0VHoMQK%7EVonHwCJx-DBIRMaLMC%7EGk-viziJK%7Er6U_&amp;Expires=1669600771&amp;Key-Pair-Id=APKAICLNFGBCWWYGVIZQ" alt="" class="lazyload" data-proofer-ignore></a>Open full size image</p><p>LLL, left lower lobe; LUL, left upper lobe; MDL, most diseased lung lobe; RA 950 , relative area of computed tomography density histogram with attenuation values of &lt;−950 HU; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; VDP, ventilation defect percent.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>VDP and RA 950 Agreement for Identifying and Ranking the Most Diseased Lobes</p><p>Most Diseased Lung Lobe VDP-RA 950 Agreement, <em>N</em> = 22 Cohen’s κ (Confidence Interval)<em>P</em> Value 1 15 (68%) 0.59 (0.35–0.83) &lt;0.001 1 + 2 14 (64%) 0.55 (0.32–0.78) &lt;0.001 2 12 (55%) 0.41 (0.14–0.68) &lt;0.001 3 10 (46%) 0.30 (0.04–0.55) 0.007 4 11 (50%) 0.36 (0.23–0.48) 0.001 5 12 (55%) 0.38 (0.25–0.51) 0.001</p><p>RA 950 , relative area of computed tomography density histogram with attenuation values of &lt;−950 HU; VDP, ventilation defect percent.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OnthePotentialRoleofMRIBiomarkersofCOPDtoGuideBronchoscopicLungVolumeReduction/1_1s20S1076633217303689.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OnthePotentialRoleofMRIBiomarkersofCOPDtoGuideBronchoscopicLungVolumeReduction/1_1s20S1076633217303689.jpg" alt="Figure 2, MRI and CT bronchoscopic lung volume reduction targets in four participants with severe emphysema. ( a ) Subject S18 (male, age = 63 years, FEV 1 = 38% pred , DL CO = 40% pred ). The RUL was identified as the most diseased lobe using CT RA 950 = 12%, whereas MRI identified the RLL as the most diseased lobe (VDP = 65%). The lower lobes showed a relatively mild emphysema but significant MRI ventilation defects. ( b ) Subject S19 (male, age = 85 years, FEV 1 = 38% pred , DL CO = 36% pred ). The LUL was identified as the most diseased lobe using RA 950 = 23%, whereas MRI identified the LLL as the most diseased lobe using VDP = 54%. ( c ) Subject S13 (male, age = 75 years, FEV 1 = 28% pred , DL CO = 17% pred ). Both MRI (VDP = 58%) and CT (RA 950 = 38%) identified the RLL as the most diseased lobe. The second–most diseased lobe based on RA 950 identified the RUL and LLL (RUL: RA 950 = 32%, LLL: RA 950 = 30%) with VDP significantly greater in the LLL (LLL: VDP = 41%, RUL: VDP = 24%). ( d ) Subject S10 (female, age = 65 years, FEV 1 = 39% pred , DL CO = 63% pred ). RA 950 was the same in all lobes (RUL, RML, LUL, and LLL: RA 950 = 8%, RLL: RA 950 = 9%), and the lower lobes showed significant ventilation defects (RLL: VDP = 32%, LLL: VDP = 33%). Color outlines indicate the segmented lobe delineations ( red = RUL, purple = RML, gold = RLL, green = LUL, and blue = LLL). Arrows indicate spatial discordance of the ventilation defect and the emphysema regions. CT, computed tomography; FEV 1 , forced expiratory volume in 1 second; LLL, left lower lobe; LUL, left upper lobe; MRI, magnetic resonance imaging; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; VDP, ventilation defect percent." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OnthePotentialRoleofMRIBiomarkersofCOPDtoGuideBronchoscopicLungVolumeReduction/2_1s20S1076633217303689.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/OnthePotentialRoleofMRIBiomarkersofCOPDtoGuideBronchoscopicLungVolumeReduction/2_1s20S1076633217303689.jpg" alt="Figure 3, Identification of potential therapy targets using functional gas MRI coregistered to structural. Three-dimensional coregistration of 3 He MRI ventilation ( cyan ) and CT ( grayscale ) with CT airway tree ( brown ) and CT RA 950 ( yellow ). ( a ) Subject S19, described in Figure 2 , with the left upper lobe as the most diseased lobe using RA 950 = 23% and MRI VDP = 54% in LLL. ( b ) Subject S10, described in Figure 2 , with RA 950 = 8%–9% in all lobes and the lower lobes showed significant ventilation defects (VDP = 32% in LLL and VDP = 33% in the LLL). A, anterior; CT, computed tomography; I, inferior; L, left; LLL, left lower lobe; MRI, magnetic resonance imaging; P, posterior; R, right; S, superior; VDP, ventilation defect percent." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="supplementary-data"><span class="mr-2">Supplementary Data</span><a href="#supplementary-data" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Video S1</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Hogg J.C., Chu F., Utokaparch S., et. al.: The nature of small-airway obstruction in chronic obstructive pulmonary disease. NEJM 2004; 350: pp. 2645-2653.</p><li><p>2. Pauwels R.A., Buist A.S., Calverley P.M., et. al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: pp. 1256-1276.</p><li><p>3. Hurst J.R., Vestbo J., Anzueto A., et. al.: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: pp. 1128-1138.</p><li><p>4. Thomas M., Decramer M., O’Donnell D.E.: No room to breathe: the importance of lung hyperinflation in COPD. Prim Care Respir J 2013; 22: pp. 101-111.</p><li><p>5. Herth F.J., Gompelmann D., Ernst A., et. al.: Endoscopic lung volume reduction. Respiration 2009; 79: pp. 5-13.</p><li><p>6. Deslee G., Klooster K., Hetzel M., et. al.: Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax 2014; 69: pp. 980-986.</p><li><p>7. Herth F.J., Valipour A., Shah P.L., et. al.: Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med 2016; 4: pp. 185-193.</p><li><p>8. Brenner M., Yusen R., McKenna R., et. al.: Lung volume reduction surgery for emphysema. Chest 1996; 110: pp. 205-218.</p><li><p>9. Cooper J.D., Patterson G.A., Sundaresan R.S., et. al.: Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996; 112: pp. 1319-1329. discussion 29–30</p><li><p>10. Group NETTR.: Patients at high risk of death after lung-volume–reduction surgery. N Engl J Med 2001; 2001: pp. 1075-1083.</p><li><p>11. Koegelenberg C.F.N., Theron J., Bruwer J., et. al.: Endoscopic lung volume reduction in severe emphysema. S Afr Med J 2015; 105: pp. 721-723.</p><li><p>12. Naunheim K.S., Wood D.E., Mohsenifar Z., et. al.: Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg 2006; 82: pp. 431-443.</p><li><p>13. Criner G.J., Cordova F., Sternberg A.L., et. al.: The National Emphysema Treatment Trial (NETT) part II: lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med 2011; 184: pp. 881-893.</p><li><p>14. Davey C., Zoumot Z., Jordan S., et. al.: Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 2015; 386: pp. 1066-1073.</p><li><p>15. Snell G., Herth F.J., Hopkins P., et. al.: Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012; 39: pp. 1326-1333.</p><li><p>16. Shah P.L., Zoumot Z., Singh S., et. al.: Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013; 1: pp. 233-240.</p><li><p>17. Klooster K., ten Hacken N.H., Hartman J.E., et. al.: Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 2015; 373: pp. 2325-2335.</p><li><p>18. Deslee G., Mal H., Dutau H., et. al.: Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS Randomized Clinical Trial. JAMA 2016; 315: pp. 175-184.</p><li><p>19. Sciurba F.C., Ernst A., Herth F.J., et. al.: A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363: pp. 1233-1244.</p><li><p>20. Fishman A., Martinez F., Naunheim K., et. al.: A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: pp. 2059-2073.</p><li><p>21. Gompelmann D., Eberhardt R., Ernst A., et. al.: The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 2013; 86: pp. 324-331.</p><li><p>22. Herth F.J., Ernst A., Baker K.M., et. al.: Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis 2012; 7: pp. 397-405.</p><li><p>23. Salerno M., de Lange E.E., Altes T.A., et. al.: Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes—initial experience. Radiology 2002; 222: pp. 252-260.</p><li><p>24. de Lange E.E., Mugler J.P., Brookeman J.R., et. al.: Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology 1999; 210: pp. 851-857.</p><li><p>25. Mathew L., Kirby M., Etemad-Rezai R., et. al.: Hyperpolarized 3 He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur J Radiol 2011; 79: pp. 140-146.</p><li><p>26. Kirby M., Pike D., Coxson H.O., et. al.: Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. Radiology 2014; 273: pp. 887-896.</p><li><p>27. Kirby M., Mathew L., Wheatley A., et. al.: Chronic obstructive pulmonary disease: longitudinal hyperpolarized 3He MR imaging 1. Radiology 2010; 256: pp. 280-289.</p><li><p>28. Parraga G., Ouriadov A., Evans A., et. al.: Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol 2007; 42: pp. 384-391.</p><li><p>29. Kauczor H.-U., Hofmann D., Kreitner K.-F., et. al.: Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging. Radiology 1996; 201: pp. 564-568.</p><li><p>30. Capaldi D.P.I., Zha N.X., Guo F.M., et. al.: Pulmonary imaging biomarkers of gas trapping and emphysema in COPD: He-3 MR imaging and CT parametric response maps. Radiology 2016; 279: pp. 597-608.</p><li><p>31. Kirby M., Svenningsen S., Owrangi A., et. al.: Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology 2012; 265: pp. 600-610.</p><li><p>32. Kirby M., Pike D., McCormack D.G., et. al.: Longitudinal computed tomography and magnetic resonance imaging of COPD: Thoracic Imaging Network of Canada (TINCan) study objectives. Chronic Obstr Pulm Dis 2014; 1: pp. 200-211.</p><li><p>33. Vestbo J., Hurd S.S., Agustí A.G., et. al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: pp. 347-365.</p><li><p>34. Schroeder J.D., McKenzie A.S., Zach J.A., et. al.: Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol 2013; 201: pp. W460-W470.</p><li><p>35. Miller M.R., Hankinson J., Brusasco V., et. al.: Standardisation of spirometry. Eur Respir J 2005; 26: pp. 319-338.</p><li><p>36. Wanger J., Clausen J.L., Coates A., et. al.: Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: pp. 511-522.</p><li><p>37. Jones P.W., Quirk F.H., Baveystock C.M.: The St George’s Respiratory Questionnaire. Respir Med 1991; 85: pp. 25-31. discussion 3–7</p><li><p>38. Holland A.E., Spruit M.A., Troosters T., et. al.: An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: pp. 1428-1446.</p><li><p>39. Kirby M., Heydarian M., Svenningsen S., et. al.: Hyperpolarized 3 He magnetic resonance functional imaging semiautomated segmentation. Acad Radiol 2012; 19: pp. 141-152.</p><li><p>40. Sheikh K., Capaldi D.P., Hoover D.A., et. al.: Magnetic resonance imaging biomarkers of chronic obstructive pulmonary disease prior to radiation therapy for non-small cell lung cancer. Eur J Radiol Open 2015; 2: pp. 81-89.</p><li><p>41. Heinrich M.P., Jenkinson M., Bhushan M., et. al.: MIND: Modality Independent Neighbourhood Descriptor for multi-modal deformable registration. Med Image Anal 2012; 16: pp. 1423-1435.</p><li><p>42. Dice L.R.: Measures of the amount of ecologic association between species. Ecology 1945; 26: pp. 297-302.</p><li><p>43. Gietema H.A., Schilham A.M., van Ginneken B., et. al.: Monitoring of smoking-induced emphysema with CT in a lung cancer screening setting: detection of real increase in extent of emphysema. Radiology 2007; 244: pp. 890-897.</p><li><p>44. McHugh M.L.: Interrater reliability: the Kappa statistic. Biochem Med (Zagreb) 2012; 22: pp. 276-282.</p><li><p>45. Shah P.L., Herth F.J.: Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax 2014; 69: pp. 280-286.</p><li><p>46. Agusti A., Calverley P.M., Celli B., et. al.: Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: pp. 122.</p><li><p>47. Martinez C.H., Chen Y.H., Westgate P.M., et. al.: Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax 2012; 67: pp. 399-406.</p><li><p>48. Gietema H.A., Edwards L.D., Coxson H.O., et. al.: Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD. Respir Med 2013; 107: pp. 1201-1209.</p><li><p>49. Iwasaki A., Shirakusa T., Enatsu S., et. al.: Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Thorac Cardiov Surg 2005; 53: pp. 162-167.</p><li><p>50. Palma D., Lagerwaard F., Rodrigues G., et. al.: Curative treatment of stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 2012; 82: pp. 1149-1156.</p><li><p>51. Colice G.L., Shafazand S., Griffin J.P., et. al.: Physiologic evaluation of the patient with lung cancer being considered for resectional surgery—ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132: pp. 161s-177s.</p><li><p>52. Kaushik S.S., Cleveland Z.I., Cofer G.P., et. al.: Diffusion-weighted hyperpolarized 129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease. Magn Reson Med 2011; 65: pp. 1154-1165.</p><li><p>53. Wild J., Collier G., Marshall H., et. al.: P283 Hyperpolarised gas MRI—a pathway to clinical diagnostic imaging. Thorax 2015; 70: pp. A220-A221.</p><li><p>54. Johnson K.M., Fain S.B., Schiebler M.L., et. al.: Optimized 3D ultrashort echo time pulmonary MRI. Magn Reson Med 2013; 70: pp. 1241-1250.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-25/'>Volume 25</a>, <a href='/categories/issue-2/'>Issue 2</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=On%20the%20Potential%20Role%20of%20MRI%20Biomarkers%20of%20COPD%20to%20Guide%20Bronchoscopic%20Lung%20Volume%20Reduction%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fon-the-potential-role-of-mri-biomarkers-of-copd-to-guide-bronchoscopic-lung-volume-reduction%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=On%20the%20Potential%20Role%20of%20MRI%20Biomarkers%20of%20COPD%20to%20Guide%20Bronchoscopic%20Lung%20Volume%20Reduction%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fon-the-potential-role-of-mri-biomarkers-of-copd-to-guide-bronchoscopic-lung-volume-reduction%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fon-the-potential-role-of-mri-biomarkers-of-copd-to-guide-bronchoscopic-lung-volume-reduction%2F&text=On%20the%20Potential%20Role%20of%20MRI%20Biomarkers%20of%20COPD%20to%20Guide%20Bronchoscopic%20Lung%20Volume%20Reduction%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/accuracy-of-computed-tomographic-enterography-for-obscure-gastrointestinal-bleeding/"><div class="card-body"> <em class="small" data-ts="1517418000" data-df="ll" > Jan 31, 2018 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Accuracy of Computed Tomographic Enterography for Obscure Gastrointestinal Bleeding</h3><div class="text-muted small"><p> Rationale and Objectives Obscure gastrointestinal bleeding (OGIB) is the bleeding from the gastrointestinal tract without definite source that persists and recurs after a negative endoscopic evalu...</p></div></div></a></div><div class="card"> <a href="/posts/apparent-diffusion-coefficient-value-to-evaluate-tumor-response-after-neoadjuvant-chemotherapy-in-pa/"><div class="card-body"> <em class="small" data-ts="1517418000" data-df="ll" > Jan 31, 2018 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Apparent Diffusion Coefficient Value to Evaluate Tumor Response After Neoadjuvant Chemotherapy in Patients with Breast Cancer</h3><div class="text-muted small"><p> Rationale and Objectives This study explored tumor behavior in patients with breast cancer during neoadjuvant chemotherapy (NAC) by sequential measurements of tumor apparent diffusion coefficient ...</p></div></div></a></div><div class="card"> <a href="/posts/automated-radiology-operative-note-communication-tool-closing-the-loop-in-musculoskeletal-imaging/"><div class="card-body"> <em class="small" data-ts="1517418000" data-df="ll" > Jan 31, 2018 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automated Radiology-Operative Note Communication Tool; Closing the Loop in Musculoskeletal Imaging</h3><div class="text-muted small"><p> Rationale and Objectives Correlation of imaging studies and reference standard outcomes is a significant challenge in radiology. This study evaluates the effectiveness of a new communication tool ...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/imaging-facilities-adherence-to-pi-rads-v2-minimum-technical-standards-for-the-performance-of-prost/" class="btn btn-outline-primary" prompt="Older"><p>Imaging Facilities' Adherence to PI-RADS v2 Minimum Technical Standards for the Performance of Prostate MRI</p></a> <a href="/posts/physician-specialty-and-radiologist-characteristics-associated-with-higher-medicare-patient-complexi/" class="btn btn-outline-primary" prompt="Newer"><p>Physician Specialty and Radiologist Characteristics Associated with Higher Medicare Patient Complexity</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
